Search Results - "Thiemann, Meinolf"
-
1
Peripheral monocytes are functionally altered and invade the CNS in ALS patients
Published in Acta neuropathologica (01-09-2016)“…Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease affecting primarily the upper and lower motor neurons. A common…”
Get full text
Journal Article -
2
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
Published in Frontiers in immunology (26-05-2023)“…The ability to modulate and enhance the anti-tumor immune responses is critical in developing novel therapies in cancer. The Tumor Necrosis Factor (TNF)…”
Get full text
Journal Article -
3
Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients
Published in Pharmaceutics (01-04-2019)“…The protein therapeutic and CD95L inhibitor asunercept is currently under clinical investigation for the treatment of glioblastoma and myelodysplastic…”
Get full text
Journal Article -
4
3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival
Published in Cell reports (Cambridge) (19-11-2019)“…The death receptor CD95 is expressed in every cancer cell, thus providing a promising tool to target cancer. Activation of CD95 can, however, lead to apoptosis…”
Get full text
Journal Article -
5
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Published in Cancer cell (01-03-2008)“…Invasion of surrounding brain tissue by isolated tumor cells represents one of the main obstacles to a curative therapy of glioblastoma multiforme. Here we…”
Get full text
Journal Article -
6
The Death Receptor CD95 Activates Adult Neural Stem Cells for Working Memory Formation and Brain Repair
Published in Cell stem cell (07-08-2009)“…Adult neurogenesis persists in the subventricular zone and the dentate gyrus and can be induced upon central nervous system injury. However, the final…”
Get full text
Journal Article -
7
HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality
Published in Journal for immunotherapy of cancer (19-07-2019)“…Glucocorticoid-induced TNFR-related protein (TNFRSF18, GITR, CD357), expressed by T cells, and its ligand (TNFSF18, GITRL), expressed by myeloid populations,…”
Get full text
Journal Article -
8
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity
Published in Frontiers in oncology (19-09-2018)“…Tumor necrosis factor receptor superfamily member 7 (TNFRSF7, CD27), expressed primarily by T cells, and its ligand CD27L (TNFSF7, CD70) provide co-stimulatory…”
Get full text
Journal Article -
9
Dynamin-like Protein 1 Is Involved in Peroxisomal Fission
Published in The Journal of biological chemistry (07-03-2003)“…The mammalian dynamin-like protein 1 (DLP1), a member of the dynamin family of large GTPases, possesses mechanochemical properties known to constrict and…”
Get full text
Journal Article -
10
Abstract 4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract The CD95 ligand (CD95L) is frequently overexpressed in cancers and tumor-associated endothelia, but also other immune cells like MDSCs and Tregs…”
Get full text
Journal Article -
11
Abstract 1587: Generation and characterization of novel bispecific molecules combining single-chain-CD40L with anti-CEA, anti-CD95L or anti-PD-L1 targeting moieties
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract CD40 ligand is a member of the TNF superfamily (TNF-SF) and a key regulator of the immune system. Its cognate receptor CD40 is expressed on…”
Get full text
Journal Article -
12
APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fcγ receptors
Published in Molecular cancer therapeutics (01-12-2013)“…Cancer cells can be specifically driven into apoptosis by activating Death-receptor-4 (DR4; TRAIL-R1) and/or Death-receptor-5 (DR5; TRAIL-R2). Albeit showing…”
Get full text
Journal Article -
13
Abstract 4460: Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract CD40 ligand is a member of the TNF superfamily and a key regulator of the immune system. Its cognate receptor CD40 is expressed on antigen-presenting…”
Get full text
Journal Article -
14
Abstract 1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract TNF Receptor Superfamily members (TNF-R-SF), including CD40, are key regulators of the immune system and have been immunotherapeutic targets for over…”
Get full text
Journal Article -
15
Abstract 1760: The hexavalent CD40 agonist HERA-CD40L augments multi-level crosstalk between T cells and antigen-presenting cells
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction: HERA-CD40L is a novel hexavalent CD40 agonist engineered with the HERA-Technology developed by Apogenix. We have previously shown that…”
Get full text
Journal Article -
16
Abstract 4143: The novel hexavalent human GITR agonist HERA-GITRL promotes anti-tumor efficacy independent of Fc-functionality and shows superior activity compared with the monoclonal anti-GITR antibody TRX518
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Glucocorticoid-induced TNFR-related protein (GITR, TNFRSF18, CD357), a TNFR-SF member, is a co-stimulatory receptor that increases anti-tumor T cell…”
Get full text
Journal Article -
17
Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Published in The Journal of experimental medicine (06-04-2015)“…Neuroinflammation is increasingly recognized as a hallmark of neurodegeneration. Activated central nervous system-resident microglia and infiltrating immune…”
Get full text
Journal Article -
18
The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells
Published in Journal of immunotherapy (1997) (01-11-2018)“…CD40 ligand (TNFSF5/CD154/CD40L), a member of the tumor necrosis factor (TNF) superfamily is a key regulator of the immune system. The cognate receptor CD40…”
Get full text
Journal Article -
19
Abstract 464: Methylation of a single CpG site in the CD95-ligand promoter is a biomarker predicting the response to therapy with APG101 in glioblastoma
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract CD95 (APO-1/Fas) is a member of the Tumor Necrosis Factor Receptor Super Family. Binding of CD95-ligand (CD95L) to CD95 triggers intracellular signal…”
Get full text
Journal Article -
20
Abstract 1688: HERA-CD40L: A novel hexavalent CD40 agonist with superior biological activity
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Introduction: Targeted therapeutics for cancer treatment are mostly developed as antibodies, however, the natural signaling complexes of the members…”
Get full text
Journal Article